Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00561223 · ClinicalTrials.gov registry record · NA
Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00561223 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 10 participants.
The verdict
NCT00561223, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators believe that iloprost will improve gas exchange in COPD patients with pulmonary hypertension.
Interventions
- DRUG iloprost
- DRUG iloprost Inhalation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-11 |
| Est. Completion | 2012-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00561223
The ClinicalTrials.gov registry entry for NCT00561223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iloprost is the first listed.
NCT00561223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00561223 about?
NCT00561223 is a clinical study titled "Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)". The investigators believe that iloprost will improve gas exchange in COPD patients with pulmonary hypertension.
What is the current status of trial NCT00561223?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2006-11. Estimated completion is 2012-10-31.
What interventions are being tested in trial NCT00561223?
The interventions under investigation include: iloprost (DRUG), iloprost Inhalation (DRUG).
Who is sponsoring clinical trial NCT00561223?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.